Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1Sanofi
02 1LGM Pharma
03 1Cohance Lifesciences
04 1Jai Radhe Sales
05 1TAPI Technology & API Services
06 1Abbott Laboratories
07 1Ajinomoto OmniChem N.V.
08 1Angene International
09 1Assurgen Pharma
10 1Aurore Life Sciences
11 1Biotechnica DWC
12 1Dasami Lab
13 1Divis Laboratories
14 1Dr. Raju’s Pharma Solutions
15 1DrugOn Pharma Switzerland
16 1Glenmark Life Sciences
17 1Guangzhou Topwork Chemical
18 1Hetero Drugs
19 2Piramal Pharma Solutions
20 1Qualitek pharma
21 1Recordati
22 1Tianish Laboratories
23 2Viatris
24 5Blank
01 1Algeria
02 1Belgium
03 1China
04 1France
05 10India
06 1Israel
07 1Italy
08 1Switzerland
09 7U.S.A
10 1United Kingdom
11 5Blank
01 9Active
02 8Inactive
03 13Blank
01 1Expired
02 9Valid
03 20Blank
01 1230MF10106
02 29Blank
01 2WC-0117
02 1WC-0119
03 1WC-0123
04 1WC-0150
05 25Blank
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6208
Submission : 1986-01-16
Status : Inactive
Type : II
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-07-02
Pay. Date : 2020-03-05
DMF Number : 34341
Submission : 2019-11-22
Status : Active
Type : II
Certificate Number : R0-CEP 2020-022 - Rev 01
Issue Date : 2022-12-15
Type : Chemical
Substance Number : 573
Status : Valid
Date of Issue : 2022-07-07
Valid Till : 2025-07-21
Written Confirmation Number : WC-0150
Address of the Firm :
NDC Package Code : 17511-132
Start Marketing Date : 2020-07-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (480kg/480kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Registrant Name : Agerson Bio Co., Ltd.
Registration Date : 2023-08-01
Registration Number : 20230801-209-J-1528
Manufacturer Name : Cohance Lifesciences Limited
Manufacturer Address : RS 50/1, Mukteswarapuram Village, Jaggaiahpeta Mandal, Krishna District-521 175. Andhra Pradesh, India
Available Reg Filing : CN |
GDUFA
DMF Review : Reviewed
Rev. Date : 2012-12-24
Pay. Date : 2012-11-13
DMF Number : 8671
Submission : 1990-07-24
Status : Active
Type : II
Certificate Number : R1-CEP 2006-098 - Rev 03
Issue Date : 2022-03-24
Type : Chemical
Substance Number : 573
Status : Valid
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-09-15
Pay. Date : 2022-05-11
DMF Number : 36808
Submission : 2022-08-02
Status : Active
Type : II
NDC Package Code : 70966-0029
Start Marketing Date : 1996-10-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-08-27
Pay. Date : 2021-06-02
DMF Number : 35691
Submission : 2021-03-23
Status : Active
Type : II
NDC Package Code : 66039-956
Start Marketing Date : 2020-11-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-04-10
Pay. Date : 2013-03-29
DMF Number : 4802
Submission : 1983-01-24
Status : Active
Type : II
Certificate Number : R1-CEP 2001-136 - Rev 03
Issue Date : 2012-01-17
Type : Chemical
Substance Number : 573
Status : Valid
Registration Number : 230MF10106
Registrant's Address : VIA M. Civitali, 1-20148 MILANO, ITALY
Initial Date of Registration : 2018-08-08
Latest Date of Registration : --
NDC Package Code : 12711-9279
Start Marketing Date : 1983-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-06-24
Pay. Date : 2013-06-17
DMF Number : 16605
Submission : 2003-05-26
Status : Active
Type : II
Certificate Number : CEP 2012-071 - Rev 02
Issue Date : 2024-08-27
Type : Chemical
Substance Number : 573
Status : Valid
Date of Issue : 2022-06-29
Valid Till : 2025-07-02
Written Confirmation Number : WC-0123
Address of the Firm :
NDC Package Code : 65085-0026
Start Marketing Date : 2006-04-19
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4817
Submission : 1983-02-22
Status : Inactive
Type : II
A Verapamil Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Verapamil Hydrochloride, including repackagers and relabelers. The FDA regulates Verapamil Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Verapamil Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Verapamil Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Verapamil Hydrochloride supplier is an individual or a company that provides Verapamil Hydrochloride active pharmaceutical ingredient (API) or Verapamil Hydrochloride finished formulations upon request. The Verapamil Hydrochloride suppliers may include Verapamil Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Verapamil Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 23 companies offering Verapamil Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?